Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C. Flint(Indiana University – Purdue University Indianapolis), Steven D. Rhodes(Indiana University Health)Clinical Cancer ResearchJuly 5, 202310.1158/1078-0432.ccr-22-2854Cited by 16SaveCiteExport RISWatch citationsRelated PapersLoss of Asxl1 leads to myelodysplastic syndrome–like disease in mice|Blood|2013|178Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression|Clinical Cancer Research|2023|24